Healthcare company StemCells Inc (NASDAQ:STEM) Declares Pricing of Public Offering to Raise $8.1 Million
A USA based company, StemCells, Inc. is presently engaged in clinical development of its HuCNS-SC platform technology (purified human neural stem cells) as a potential treatment for chronic spinal cord injury (SCI). Share of StemCells […]